enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. FDA approves weight-loss drug to treat sleep apnea - AOL

   www.aol.com/fda-approves-weight-loss-drug...

   The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the disorder affecting millions of Americans. On Friday, the federal agency ...

3. Paroxetine - Wikipedia

   en.wikipedia.org/wiki/Paroxetine

   Paroxetine, sold under the brand name Paxil among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. [7] It is used to treat major depressive disorder, obsessive–compulsive disorder (OCD), panic disorder, social anxiety disorder, post-traumatic stress disorder (PTSD), generalized anxiety disorder, and premenstrual dysphoric disorder. [7]

4. Zepbound Weight Loss Medication Approved by FDA to Treat ...

   www.aol.com/fda-approves-weight-loss-medication...

   The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.

5. Obstructive sleep apnea - Wikipedia

   en.wikipedia.org/wiki/Obstructive_sleep_apnea

   Most individuals with obstructive sleep apnea are unaware of disturbances in breathing while sleeping, even after awakening. A bed partner or family member may observe a person snoring or appear to stop breathing, gasp, or choke while sleeping. People who live or sleep alone are often unaware of the condition.

6. Temazepam - Wikipedia

   en.wikipedia.org/wiki/Temazepam

   The American Academy of Sleep Medicine's 2017 clinical practice guidelines recommended the use of temazepam in the treatment of sleep-onset and sleep-maintenance insomnia. [19] It rated the recommendation as weak, the quality of evidence as moderate, and concluded that the potential benefits outweighed the potential harms. [ 19 ]

7. Lilly's weight-loss treatment Zepbound becomes first FDA ...

   www.aol.com/news/lillys-weight-loss-drug-zep...

   The regulator approved the drug for moderate to severe obstructive sleep apnea in adults with obesity, the company said. The approval opens up a wide market of patients for Lilly at a time when ...